Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

Personalis, Inc. announced a collaboration with UC San Francisco (UCSF) that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.